BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29408167)

  • 1. Predicting cardiogenic pulmonary edema in heart failure patients by using an N-terminal pro-b-type natriuretic peptide (NT-pro BNP) -based score.
    Liu XY; Huang YT; Lai MY; Chen J; Chu TW; Tsay PK; Shiao CC
    Clin Chim Acta; 2018 May; 480():26-33. PubMed ID: 29408167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-terminal pro b-type natriuretic peptide (NT-pro-BNP) -based score can predict in-hospital mortality in patients with heart failure.
    Huang YT; Tseng YT; Chu TW; Chen J; Lai MY; Tang WR; Shiao CC
    Sci Rep; 2016 Jul; 6():29590. PubMed ID: 27411951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic and prognostic utility of brain natriuretic Peptide in subjects admitted to the ICU with hypoxic respiratory failure due to noncardiogenic and cardiogenic pulmonary edema.
    Karmpaliotis D; Kirtane AJ; Ruisi CP; Polonsky T; Malhotra A; Talmor D; Kosmidou I; Jarolim P; de Lemos JA; Sabatine MS; Gibson CM; Morrow D
    Chest; 2007 Apr; 131(4):964-71. PubMed ID: 17426196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of N-terminal pro-B-type natriuretic peptide increase with exercise for predicting cardiovascular mortality in patients with heart failure.
    Koç M; Bozkurt A; Acartürk E; Sahin DY; Unal I
    Am J Cardiol; 2008 Apr; 101(8):1157-62. PubMed ID: 18394451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary edema in patients aged 65 and older.
    Ray P; Arthaud M; Birolleau S; Isnard R; Lefort Y; Boddaert J; Riou B
    J Am Geriatr Soc; 2005 Apr; 53(4):643-8. PubMed ID: 15817011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of prognostic significance of amino-terminal pro-brain natriuretic Peptide versus blood urea nitrogen for predicting events in patients hospitalized for heart failure.
    Shenkman HJ; Zareba W; Bisognano JD
    Am J Cardiol; 2007 Apr; 99(8):1143-5. PubMed ID: 17437744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of N-terminal pro-type-B natriuretic peptide and Doppler left ventricular diastolic variables in patients with chronic systolic heart failure stabilized by therapy.
    Dini FL; Conti U; Fontanive P; Andreini D; Panicucci E; De Tommasi SM
    Am J Cardiol; 2008 Aug; 102(4):463-8. PubMed ID: 18678307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of intermediate amino-terminal pro-brain natriuretic peptide concentrations for diagnosis and prognosis of acute heart failure.
    van Kimmenade RR; Pinto YM; Bayes-Genis A; Lainchbury JG; Richards AM; Januzzi JL
    Am J Cardiol; 2006 Aug; 98(3):386-90. PubMed ID: 16860029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The accuracy of natriuretic peptides (brain natriuretic peptide and N-terminal pro-brain natriuretic) in the differentiation between transfusion-related acute lung injury and transfusion-related circulatory overload in the critically ill.
    Li G; Daniels CE; Kojicic M; Krpata T; Wilson GA; Winters JL; Moore SB; Gajic O
    Transfusion; 2009 Jan; 49(1):13-20. PubMed ID: 18954397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic peptide B plasma concentration increases in the first 12 h of pulmonary edema recovery.
    Susini F; Assanelli E; Doria E; Morpurgo M; Brusoni D; Bonomi A; Barbieri S; Cabiati A; Salvini L; Chiodelli R; Loguercio M; Galli A; Agostoni P
    Eur J Intern Med; 2018 Jul; 53():52-56. PubMed ID: 29559199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Right Ventricular Dysfunction and Diabetes Mellitus in N-terminal pro-B-type Natriuretic Peptide Response of Patients With Severe Mitral Regurgitation and Heart Failure After MitraClip.
    Kaneko H; Neuss M; Weissenborn J; Butter C
    Int Heart J; 2017 Apr; 58(2):225-231. PubMed ID: 28216549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual variation of amino-terminal pro-B-type natriuretic peptide levels in patients with stable heart failure.
    Araújo JP; Azevedo A; Lourenço P; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    Am J Cardiol; 2006 Nov; 98(9):1248-50. PubMed ID: 17056340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type B natriuretic peptide (BNP) versus n-terminal type B natriuretic propeptide in the diagnosis of cardiac failure in the elderly over 75 population].
    El Mahmoud R; Alibay Y; Brun-Ney D; Boulard JC; Dubourg O; Puy H; Jondeau G
    Arch Mal Coeur Vaiss; 2006 Mar; 99(3):201-7. PubMed ID: 16618022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.